Harmonised Filing System For Plant Variety Protection Discussed At UPOV 16/04/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment An industry proposal calling for a harmonised procedure to simplify applications for new varieties of plants and heighten intellectual property protection stirred debate at the International Union for the Protection of New Varieties of Plants (UPOV) last month.
Experts Debate Medicines Access In South Africa And Beyond 15/04/2015 by Linda Daniels for Intellectual Property Watch 2 Comments CAPE TOWN – Pharmaceutical patents and access to medicines was the focus of an animated panel discussion by experts offering divergent views on the topic at intellectual property group FICPI’s 2015 World Congress, currently underway in Cape Town, South Africa.
Clinical Trial Transparency, Medicines Access On Agendas Today 14/04/2015 by William New, Intellectual Property Watch Leave a Comment The World Health Organization today issued a call for disclosure of results from clinical trials for medical products, no matter what the results of the trials were. And a variety of events and publications are addressing medicines access today.
Yale Conference Looks At Innovation “Beyond IP” 12/04/2015 by William New, Intellectual Property Watch 1 Comment NEW HAVEN – Intellectual property is not the only driver of human innovation. A two-day conference held here recently brought together a range of leading academics and others to share ideas on innovation occurring outside of, or in spite of, intellectual property rights.
The Shaky Rationale For TPP’s Copyright Term 06/04/2015 by Steven Seidenberg for Intellectual Property Watch 2 Comments The Trans-Pacific Partnership (TPP) is supposed to be a free trade agreement among 12 Pacific Rim nations. But the TPP also includes some contentious intellectual property provisions, including a requirement that all member states have a minimum copyright term of life plus 70 years – thus forcing six nations to increase their copyright terms by 20 years. This copyright term extension is strongly criticised by some experts, who claim it is antithetical to the goals of copyright law. Moreover, this copyright term extension runs counter to the stance of the US Copyright Office, which has been trying to weaken the current US copyright term of life-plus-70. [Note: Part 2 of 2 articles]
EPO Backs Patents On Conventional Plants: Broccoli, Tomato Cases Decided 01/04/2015 by Catherine Saez, Intellectual Property Watch 12 Comments The highest court of the European Patent Office has declared that plants or seeds obtained through conventional breeding methods are patentable.
Panel: Open Data, Open Access, And Open Education – Key To Open Innovation? 31/03/2015 by Elena Bourtchouladze for Intellectual Property Watch 1 Comment Intellectual property stimulates creativity but at the same time holds back innovation, speakers said at a recent event on open innovation and alternative business models. The roundtable looked a range of models, such as open source and open data, and their advantages, to “all rights reserved” protection.
Manila Principles On Intermediary Liability Offer Vision For Balance 27/03/2015 by William New, Intellectual Property Watch 1 Comment A new set of principles launched this week by a range of global non-governmental organisations attempts to set out guidelines for internet intermediaries’ liability for content of communications. The six principles, which are seeking endorsement from organisations and individuals worldwide, address freedom of expression, freedom of association, and the right to privacy.
How The Leaked TPP ISDS Chapter Threatens Intellectual Property Limitations and Exceptions 26/03/2015 by Intellectual Property Watch 6 Comments By Prof. Sean Flynn, Associate Director, Program on Information Justice and Intellectual Property (PIJIP), American University Washington College of Law Reposted with permission from Infojustice.org, original here. I released a statement earlier today opining that the today’s leak of the Investor State Dispute Settlement (ISDS) chapter proposed for the Trans Pacific Partnership (TPP) agreement (available […]
Indian Draft Pesticides Bill Contains TRIPS-Plus Data Exclusivity, Indian Pharma Says 26/03/2015 by Catherine Saez, Intellectual Property Watch 3 Comments India is considering legislation on pesticides containing data exclusivity provisions that would raise the level of intellectual property protection above the minimum required by international trade agreements and could act as a precursor for pharmaceutical products in the country, a leading Indian industry representative warned this week. India is sensitive to restrictions on the use of marketing data of patented pharmaceuticals as it is seen as the world leader in generic medicines, which use such data.